Industry-Academia Collaboration

Industry-Academia Collaboration

Compared to conventional pharmaceuticals, regenerative medicine requires more intense collaboration between industry and academia from the earliest stages of development. The value chain of this field presents a completely new model for industry-academia collaborations. It is becoming clear that both industry and academia need to work in partnership to develop products and services, beginning in the early stages.

 

Product development in the field of regenerative medicine is still far from reaching its full potential. This module aims to create pathways toward product creation and build a regenerative medicine ecosystem. JSRM is carrying out the following activities as part of its vital role as an intermediary between academia and industry:

 

  • Organizing Value Chain Seminars for Industry-Academia Collaboration in Regenerative Medicine to pinpoint specific topics related to regenerative medicine in various industries, deepening discussions utilizing perspectives from both industry and academia, as well as identifying issues and finding solutions.
  • Regenerative Medicine Techno-Auctions to assist with the exploration of possible business opportunities. JSRM will work to clarify issues related to intellectual property before introducing potential business seeds within academia to industry partners.
  • Providing other support for clinical research (including clinical testing) by acting as a liaison between clinical research modules and organizations.

 

Through these activities, JSRM will assist organizations in overcoming the innovation “valley of death,” and build a scheme to create products and services related to regenerative medicine involving partnerships between industry and academia from the earliest stages of development.

 


 

3rd Value Chain Seminar for Industry-Academia Collaboration in Regenerative Medicine
An Overview of FIRM Standards and Guidelines

Event Report (October 1, 2018)

 

 

On October 1, 2018, the 3rd Value Chain Seminar for Industry-Academia Collaboration in Regenerative Medicine – An Overview of FIRM Standards and Guidelines – was held in Nihonbashi, Tokyo.

 

The event, held with the cooperation of FIRM, provided an overview of FIRM standards and guidelines.

A keynote speech and educational presentations were held in addition to an explanation about FIRM standards entitled “Examples of Testing/Inspection Methods and Equipment from FIRM (Part 1) – Cell Quality Control in Accordance with the Act on the Safety of Regenerative Medicine.” The informative presentations helped to further attendees’ understanding of the theme of the seminar – Testing/Inspection and Inspection Equipment.

 

Presentation materials from the seminar can be downloaded from the link below. (* Materials may differ from those handed out on the day.)

[Presentation Materials from the 3rd Value Chain Seminar for Industry-Academia Collaboration in Regenerative Medicine – An Overview of Firm Standards and Guidelines]

 

For materials from the “Examples of Testing/Inspection Methods and Equipment from FIRM (Part 1) – Cell Quality Control in Accordance with the Act on the Safety of Regenerative Medicine” presentation, please contact the FIRM Secretariat.

 

FIRM Secretariat: info@firm.or.jp

 


 

1st Techno Auction for Industry-Academia Collaboration in Regenerative Medicine

Event Report (March 22, 2018)

 

The 1st Techno Auction for Industry-Academia Collaboration in Regenerative Medicine was held at Pacifico Yokohama on Thursday, March 22, 2018, from 5:50 to 6:50 pm. The event was extremely successful with close to 200 participants – almost double the expected number of attendees.

 

The event also included a short seminar on intellectual property (presented by Ryo Funakoshi, Osaka University) and presentations about the 10 business seeds listed below. Click on the images below to see an overview of the business seeds presented on the day and the contact details of the researchers involved.

 

We hope that this information will provide opportunities to advance the establishment of a regenerative medicine industry.

 

[*Click on the images below to view the PDF files.]

 

 


 

Seed No. 1: Seiichi Yokoo (Minimum Labo/Kyoto Prefectural University of Medicine)

Achieving Individualized Regenerative Medicine Using Single-Use Systems

 

 


 

Seed No. 2: Naosuke Kamei (Department of Orthopaedic Surgery, Graduate School of Biomedical Sciences, Hiroshima University)

Cartilage Regeneration Project Using Magnetic Targeting

 

 


 

Seed No. 3: Kenichi Tezuka (Graduate School of Medicine, Gifu University)

iPS Cells From Discarded Teeth – Providing Safer Regenerative Medicine to the World

 

 


 

Seed No. 4: Akira Nakada (Kyoto Industrial Health Association)

Development of a New Collagen Scaffold Material to Ensure Space-Maintenance and Tissue Affinity for Regeneration in vivo

 

 


 

Seed No. 5: Ryo Takagi (Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University)

Closure of Lung Air Leakage Using an Autologous Cultured Dermal Fibroblast Sealant

 

 


 

Seed No. 6: Kazuyuki Otsuka (Osaka Bio-Medical College)

Creating Insulin-Producing Cells from Cultured Peripheral Blood Leucocytes and Utilizing Autologous Cells to Build a Cell Processing Method for Regenerative Medicine in Diabetes Treatment

 

 


 

Seed No. 7: Satsuki Yamada (Mayo Clinic)

Regenerative Medicine Partnerships with the Mayo Clinic

 

 


 

Seed No. 8 Kenji Orimoto (General Internal Medicine Department, Fureai Higashi Totsuka Hospital)

Developing Treatment for Rett Syndrome Using Gene Editing Technology

 

 


 

Seed No. 9: Toshiaki Takezawa(Division of Food Function Research, National Agriculture and Food Research Organization

A Cell Encapsulation Device Using Processed Atelocollagen Vitrigel Developed to Revolutionize Culturing Techniques for Transplanted Cells

 

 


 

Seed No. 10: Taro Matsumoto (Nihon University School of Medicine)

Regenerative Medicine Using a Mature Fat Cell Dedifferentiation Technique